FDA approves ODACTRA® for the treatment of house dust mite allergy in young children | ALK Poland

FDA approves ODACTRA® for the treatment of house dust mite allergy in young children

Link

https://www.globenewswire.com/news-release/2025/02/27/3034245/0/en/FDA-approves…

Created date

Thu, 02/27/2025 - 12:00

Nasdaq ID

3034245

Last updated: 2025.02.27